Matinas BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.About MTNB
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access.
CEOJerome D. Jabbour
CEOJerome D. Jabbour
Employees7
Employees7
HeadquartersBedminster, New Jersey
HeadquartersBedminster, New Jersey
Founded2013
Founded2013
Employees7
Employees7
MTNB Key Statistics
Market cap4.96M
Market cap4.96M
Price-Earnings ratio-0.22
Price-Earnings ratio-0.22
Dividend yield—
Dividend yield—
Average volume35.19K
Average volume35.19K
High today$0.85
High today$0.85
Low today$0.76
Low today$0.76
Open price$0.76
Open price$0.76
Volume37.29K
Volume37.29K
52 Week high$3.09
52 Week high$3.09
52 Week low$0.4748
52 Week low$0.4748
Stock Snapshot
Matinas BioPharma(MTNB) stock is priced at $0.79, giving the company a market capitalization of 4.96M. It carries a P/E multiple of -0.22.
As of 2025-12-04, Matinas BioPharma(MTNB) stock has fluctuated between $0.76 and $0.85. The current price stands at $0.79, placing the stock +3.5% above today's low and -7.5% off the high.
Matinas BioPharma(MTNB) shares are trading with a volume of 37.29K, against a daily average of 35.19K.
In the last year, Matinas BioPharma(MTNB) shares hit a 52-week high of $3.09 and a 52-week low of $0.47.
In the last year, Matinas BioPharma(MTNB) shares hit a 52-week high of $3.09 and a 52-week low of $0.47.
People also own
Based on the portfolios of people who own MTNB. This list is generated using Robinhood data, and it’s not a recommendation.